Legislative, Regulatory & Legal

Fred’s Pharmacy confirmed its agreement to purchase divested stores remains in effect following Monday’s news that Walgreens Boots Alliance and Rite Aid extended the deadline for their potential merger agreement.  

An Evercore ISI analyst maintained his “buy” rating on Walgreens Boots Alliance stock, stating that although its proposed deadline for a deal with Rite Aid has been delayed, “there is still a chance of a reasonable outcome for both parties.”   The companies pushed back the deadline for merger from Jan. 27 to July 31 and trimmed the purchase price paid to Rite Aid to $6.50 to $7 per share — based upon the number of store divestitures the FTC requires — from $9 per share.  

According to a 2015 Nielsen study, two-thirds of consumers trust consumer opinions over company advertising and rely on peer review sites for insights and advice. However, these sites can cause huge headaches for well-intentioned retailers that incentivize consumers to post glowing reviews or find themselves on the wrong side of a revenge or competitor-sponsored post. When not conducted correctly, these efforts can harm brands and further consumer mistrust.   

Starbucks Corp. is living up to its reputation as one of the nation’s most socially progressive retailers.    On the heels of President Donald Trump's indefinite suspension of Syrian refugees and temporary travel bans that apply to seven predominantly Muslim countries, the coffee giant pledged to hire 10,000 refugees to work at its stores around the world during the next five years.  

Walgreens Boots Alliance and Rite Aid on Monday morning extended their previously announced definitive merger agreement under which Walgreens Boots Alliance will acquire all outstanding shares of Rite Aid.   The retail pharmacy operations also restructured a new deal that would value Rite Aid at between about $6.8 billion and $7.4 billion, depending on required store divestitures, down from an initial acquisition cost of $9.4 billion.  

With the deadline for the deal set to expire Friday, Jan. 27, Walgreens Boots Alliance CEO Stefano Pessina told shareholders attending the Walgreens Boots Alliance annual meeting Thursday morning that the board of directors for both Walgreens and Rite Aid were in "active" discussions toward getting the deal approved even as the Federal Trade Commission continues to deliberate over the proposed retail pharmacy merger.  

Although it’s only one of many tax proposals being floating around, the so-called border adjustment tax has raised a red flag among many retailers.    The CEO of Target Corp., Brian Cornell, recently visited Washington to lobby against the House Republican proposal, according to Fortune, which noted the visit was first reported by Politico.  

The much anticipated approval for the Walgreens/Rite Aid merger, through which Walgreens has proposed to pay $9.4 billion for the acquisition of Rite Aid's 4,547 stores in an effort to bolster its national footprint, did not happen by Friday morning as many had speculated.    Now there is a new countdown clock — the deal is set to expire Jan. 27 if not approved before that time.